Tony W. Ho, Executive VP, Head of R&D at CRISPR Therapeutics AG (CRSP), sold 6,700 shares at $70.14 ($470K) on 2020-05-26, disclosed to the SEC on 2020-05-27.
Open-market sale of $470k CRSP by Executive VP, Head of R&D. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $70.05 | 600 | $42K | 8.9% |
| 2 | $70.14 | 6,100 | $428K | 91.1% |
| Total | $70.13 avg | 6,700 | $470K | 100% |
| Filing → |